KANO, Nigeria (Azat TV) – In maternity wards across Nigeria, a simple, green plastic sheet costing less than a dollar is fundamentally altering the management of postpartum hemorrhage, the leading cause of maternal mortality worldwide. Reported in an article published by DNyuz on November 3, 2026, the device — known as a maternal drape — sits beneath a woman during delivery with a calibrated pouch hanging off the edge of the bed. When blood entering the pouch surpasses the 300-milliliter danger mark, medical staff immediately deploy a synchronized package of treatments rather than waiting for visual estimates that routinely obscure life-threatening blood loss.
Postpartum hemorrhage occurs after delivery when the placenta separates and hundreds of open blood vessels fail to close due to insufficient uterine contractions. While roughly one in ten women experiences excessive postpartum bleeding, the vast majority of the estimated 70,000 annual global deaths occur in low-income nations with strained healthcare infrastructure. Nigeria bears a particularly heavy toll due to widespread anemia, limited prenatal care, and severe shortages of skilled midwives and obstetricians, especially in rural regions where maternal risks compound with each successive birth.
The Clinical Mechanics of the Plastic Drape and Treatment Bundle
The intervention’s effectiveness relies on eliminating the dangerous subjectivity of visual estimation. Historically, doctors and midwives consistently underestimated blood loss because pooling fluids on sheets and floors are notoriously difficult to quantify visually. By the time clinicians recognized an emergency, patients had often slipped into critical condition. The maternal drape provides an exact measurement, removing guesswork and triggering an immediate response.
Once the 300-milliliter threshold is crossed, nurses execute a simultaneous bundle of four interventions: administering oxytocin via intravenous injection to stimulate uterine contractions, providing tranexamic acid to encourage blood clotting, massaging the patient’s abdomen, and starting intravenous fluids to stabilize blood volume. Clinical trials demonstrated that deploying these measures simultaneously rather than sequentially cuts hospital deaths from postpartum hemorrhage by roughly two-thirds, transforming a potentially fatal emergency into a manageable routine.
National Rollout and Institutional Skepticism
Dr. Hadiza Galadanci, a professor of obstetrics and gynecology at Bayero University in Kano who oversaw the Nigerian research into the drape, initially approached the device with skepticism. However, clinical findings convinced her to campaign for its adoption as a national standard of care. Pairs of specialized midwife-trainers are now visiting maternity wards across Nigeria to introduce the drape and treatment bundle to skeptical medical staff who are accustomed to traditional, delayed intervention protocols.
Frontline healthcare workers report dramatic results once the bundle is implemented. Binta Garba, head nurse in the labor ward at Aminu Kano Teaching Hospital, noted that the facility has not recorded a single maternal death from postpartum hemorrhage since adopting the protocol, with teams successfully deploying the bundle multiple times every week. While high-income countries rely on one-on-one nursing, continuous electronic monitoring, and readily available blood banks to manage bleeding, this low-tech protocol offers a scalable model for resource-constrained health systems worldwide.
Broader Trials, Global Policy Shifts, and Economic Scaling
Recent multi-center clinical trials involving more than 20,000 women across countries including Nigeria, Kenya, Tanzania, and South Africa — published in medical journals such as The Lancet — have demonstrated that the calibrated drape and simultaneous treatment bundle reduce severe bleeding, surgical intervention, or death by up to 60 percent. Adam Devall, Professor of Maternal Health Clinical Trials at the University of Oxford, noted that such effect sizes are exceptionally rare in decades of clinical research. The intervention successfully elevated detection rates from roughly 50 percent under traditional visual monitoring up to 90 percent during the trials.
To overcome initial reliance on imported equipment, health authorities collaborated with local manufacturers. Through a $600,000 grant from the Gates Foundation, a Kano-based manufacturing firm, Systs Engineering, was equipped to produce the drapes locally. Although raw material costs have risen due to regional conflicts, the drapes are distributed to Nigeria’s national health system at approximately 80 cents each. Furthermore, well-resourced environments are beginning to integrate the findings, with organizations like NHS England incorporating the drape recommendations into their own maternity care bundles.
Frontline Challenges and Community-Level Expansion
Despite significant hospital-level successes, systemic hurdles persist across Nigeria’s decentralized health network. Severe understaffing means that drapes occasionally go unmonitored for extended periods, and many women still give birth outside clinical environments entirely. Approximately 60 percent of Nigerian women deliver at home, where risks are compounded by high baseline rates of maternal anemia and limited access to professional obstetric care.
To address out-of-hospital fatalities, Dr. Galadanci’s research team is actively testing community health worker kits tailored for home births. These kits feature absorbent mats marked with critical saturation thresholds and doses of misoprostol to stimulate uterine contractions during emergency transit. As medical teams continue scaling the protocol for hospital deliveries and community settings alike, this low-cost innovation provides a vital operational framework for protecting mothers where high-tech infrastructure is absent.